Nephrology
1 drug is in development for Alport Syndrome.
- Companies
- 1
- Clinical trials
- 7
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Alport Syndrome pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Preclinical(1)
| Drug | Company |
|---|---|
| var 200 | ZyVersa Therapeutics, Inc. (ZVSA) |
About this indication
Alport Syndrome context
Nephrology·MeSH: Nephritis, Hereditary (D009394)
Frequently asked questions
How many drugs are in development for Alport Syndrome?
BioSniper tracks 1 drug in development for Alport Syndrome across 1 company.
How many clinical trials target Alport Syndrome?
There are 7 clinical trials targeting Alport Syndrome tracked by BioSniper.